ELISA Kit for Carboxymethyl Lysine (CML) View larger

ELISA Kit for Carboxymethyl Lysine (CML)

CC-CEB977Ge

New product

48T, 96T, 96T×5, 96T×10, 96T×100

More details

Registe-se for viewing this price!

Ao comprar este produto pode ganhar até 8 pontos de fidelização. Seu carrinho totalizará 8 pontos de fidelização que podem ser convertidos num vale de desconto de 32.00EUR.


Data sheet

Size 96T
Storage Conditions -20°C
Shipping Conditions Entre 4°C y 8°C
Applications Enzyme-linked immunosorbent assay for Antigen Detection.
Detection Range 61.7-5,000ng/mL
Sensitivity The minimum detectable dose of this kit is typically less than 25.9ng/mL
Research Area Metabolic pathway
Organism species Pan-species (General)
Alternative Names N(6)-Carboxymethyllysine
Item Name Carboxymethyl Lysine
Assay Length 2h
Method Competitive Inhibition
Sample Type Serum, plasma and other biological fluids
Formato 48T, <i>96T</i>, 96T×5, 96T×10, 96T×100
Test Principle This assay employs the competitive inhibition enzyme immunoassay technique. A monoclonal antibody specific to Carboxymethyl Lysine (CML) has been pre-coated onto a microplate. A competitive inhibition reaction is launched between biotin labeled Carboxymet
Assay procedure summary 1. Prepare all reagents, samples and standards
UniProt ID -

More info

Click here for manual in PDF

Click here for OD Image


CITATIONS
Advanced Glycation End Products Induce Human Corneal Epithelial Cells Apoptosis through Generation of Reactive Oxygen Species and Activation of JNK and p38 MAPK Pathways;Effects of combined lipoic acid and pyridoxine on albuminuria, advanced glycation end-products, and blood pressure in diabetic nephropathy.;Advanced glycation end-products accelerate the cardiac aging process through the receptor for advanced glycation end-products/transforming growth factor-β-Smad signaling pathway in cardiac fibroblasts;Inhibition of Advanced Glycation Endproduct Formation by Lotus Seedpod Oligomeric Procyanidins through RAGE-MAPK Signaling and NF-κB Activation in High-Fat-Diet Rats.;Association of serum N Îľ-Carboxy methyl lysine with severity of diabetic retinopathy;Hyperoside reduces albuminuria in diabetic nephropathy at the early stage through ameliorating renal damage and podocyte injury.;Increased levels of N(ε)- Carboxy methyl lysine (N(ε)-CML) are associated with topographic alterations in retinal pigment epithelium: A preliminary study;Long-term administration of advanced glycation end-product stimulates the activation of NLRP3 inflammasome and sparking the development of renal injury.;Plasma heparanase is associated with blood glucose levels but not urinary microalbumin excretion in type 2 diabetic nephropathy at the early stage ;High intake of dietary advanced glycation end-products is associated with increased arterial stiffness and inflammation in subjects with type 2 diabetes.;Antiglycation and antioxidant activities of mogroside extract from (Swingle) fruits;Elevated advanced glycation end products are associated with subfoveal ellipsoid zone disruption in diabetic macular edema;